BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Non-GAAP Adjusted Diluted Earnings per Ordinary Share by Quarter
Non-GAAP Adjusted Diluted Earnings (Loss) per Ordinary Share ($/sh) ($)
BeOne Medicines Non-GAAP Adjusted Diluted Earnings per Ordinary Share: $0.30 in Q2 2026, up 76.5% from a year earlier. That is the highest of the 10 quarters on record here.
Where the Q2 2026 figure comes from
“|| Adjusted earnings per share - diluted | $ | 0.30 | $ | 0.17 | $ | 0.54 | $ | 0.27”
Source: Form 8-K (filed 2026-08-05) ↗
Reported in Form 8-K EX-99.1 Non-GAAP Reconciliation Tables.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Adjusted Diluted Earnings (Loss) per Ordinary Share ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 0.30 | +76.5% | Form 8-K (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 0.25 | +177.8% | Form 8-K (filed 2026-05-06) ↗ |
| Q4 2025 | Dec 31, 2025 | 0.15 | +1,400.0% | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 30, 2025 | 0.20 | +400.0% | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 0.17 | +750.0% | Form 8-K (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 0.09 | -181.8% | Form 8-K (filed 2025-05-07) ↗ |
| Q4 2024 | Dec 31, 2024 | 0.01 | – | Form 8-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 0.04 | – | Form 8-K (filed 2025-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 0.02 | – | Form 8-K (filed 2025-08-06) ↗ |
| Q1 2024 | Mar 31, 2024 | -0.11 | – | Form 8-K (filed 2025-05-07) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Non-GAAP Adjusted Diluted Earnings per Ordinary Share ($), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/adj-eps-diluted
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.